Cargando…
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity
Myasthenia gravis (MG) is a T cell-dependent, B cell-mediated disease. The mechanisms for loss of self-tolerance in this disease are not well understood, and recently described regulatory B cell (Breg) subsets have not been thoroughly investigated. B10 cells are a subset of Bregs identified by the p...
Autores principales: | Yi, John S., Russo, Melissa A., Massey, Janice M., Juel, Vern, Hobson-Webb, Lisa D., Gable, Karissa, Raja, Shruti M., Balderson, Kristina, Weinhold, Kent J., Guptill, Jeffrey T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301008/ https://www.ncbi.nlm.nih.gov/pubmed/28239367 http://dx.doi.org/10.3389/fneur.2017.00034 |
Ejemplares similares
-
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007) -
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis
por: Gable, Karissa L., et al.
Publicado: (2020) -
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
por: Guptill, Jeffrey T., et al.
Publicado: (2015) -
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis
por: Masi, Gianvito, et al.
Publicado: (2023) -
Clinical outcome measures following plasma exchange for MG exacerbation
por: Raja, Shruti M., et al.
Publicado: (2019)